EverSource Wealth Advisors’s Inozyme Pharma INZY Stock Holding History

EverSource Wealth Advisors’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-270	Closed	-$1.08K	–	4403
2025 Q2	$1.08K	Sell	270 -125	-32%	-$310	﹤0.01%	3714
2025 Q1	$359	Buy	395 +390	+7,800%	+$541	﹤0.01%	3567
2024 Q4	$14	Buy	+5	New	+$19	﹤0.01%	3725

EverSource Wealth Advisors's INZY Position: Q3 2025 in Review

EverSource Wealth Advisors sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 270 shares — an estimated $1.08K sold.

EverSource Wealth Advisors first reported a position in INZY in Q4 2024 and held it in 3 quarters. The position peaked at $1.08K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

EverSource Wealth Advisors reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
EverSource Wealth Advisors sold 270 Inozyme Pharma shares in Q3 2025, an estimated $1.08K.
EverSource Wealth Advisors first reported a position in Inozyme Pharma in Q4 2024 and held it in 3 quarters.
EverSource Wealth Advisors's Inozyme Pharma position peaked at $1.08K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on EverSource Wealth Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.